Israeli leukemia treatment approved for UK children

The breakthrough CAR-T personalized leukemia therapy devised by Professor Zelig Eshhar of Israel’s Weizmann Institute (see here) is now available in the UK.  The National Health Service will fund Kymriah – the CAR-T treatment commercialized by Novartis.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *